It is important to discuss with your doctor your personal health needs and they should be able to assess a safe, suitable and effective treatment plan for you
230 adults who are obese or overweight (average BMI ~39.5) were randomly assigned to take a placebo, or aleniglipron at one of three doses (45mg, 90mg, or 120mg) for 36 weeks, with the dose gradually increasing over time
In the SELECT trial which followed over 17,600 people across several years semaglutide reduced the risk of heart attack, stroke, or cardiovascular death by 20% in adults with existing heart disease and obesity or overweight
Hypothyroidism is diagnosed in patients with PWS with a prevalence ranging 472% [40, 41]
, your health and safety are our top priorities